The Current Ratio as of December 2025 (TTM) for Tasly Pharmaceutical Group Co., Ltd (600535.SS) is 3.82

According to Tasly Pharmaceutical Group Co., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 3.82. This represents a change of 15.45% compared to the average of 3.31 of the last 4 quarters.

Tasly Pharmaceutical Group Co., Ltd (600535.SS) Historical Current Ratio (quarterly & annually)

How has 600535.SS Current Ratio performed in the past?

The mean historical Current Ratio of Tasly Pharmaceutical Group Co., Ltd over the last ten years is 2.76. The current 3.82 Current Ratio has changed 13.75% with respect to the historical average. Over the past ten years (40 quarters), 600535.SS's Current Ratio was at its highest in in the September 2021 quarter at 6.19. The Current Ratio was at its lowest in in the September 2017 quarter at 1.24.

Tasly Pharmaceutical Group Co., Ltd (600535.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tasly Pharmaceutical Group Co., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tasly Pharmaceutical Group Co., Ltd (600535.SS) Average Current Ratio

How has 600535.SS Current Ratio performed in the past?

The current Current Ratio of Tasly Pharmaceutical Group Co., Ltd (600535.SS) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Tasly Pharmaceutical Group Co., Ltd (600535.SS) Current Ratio vs. Peers

How is 600535.SS’s Current Ratio compared to its peers?

Tasly Pharmaceutical Group Co., Ltd’s Current Ratio is less than Hubei Jumpcan Pharmaceutical Co., Ltd. (5.32), greater than Joincare Pharmaceutical Group Industry Co.,Ltd. (2.63), greater than China National Medicines Corporation Ltd. (2.15), less than Jiangsu Nhwa Pharmaceutical Co., Ltd. (7.29), greater than Jilin Aodong Pharmaceutical Group Co., Ltd. (2.14), greater than China Resources Double-Crane Pharmaceutical Co.,Ltd. (2.25), greater than ApicHope Pharmaceutical Co., Ltd (1.49), greater than Betta Pharmaceuticals Co., Ltd. (0.77), greater than Apeloa Pharmaceutical Co.,Ltd (1.43), greater than Autobio Diagnostics Co., Ltd. (2.58),

Build a custom stock screener for Tasly Pharmaceutical Group Co., Ltd (600535.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tasly Pharmaceutical Group Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tasly Pharmaceutical Group Co., Ltd (600535.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tasly Pharmaceutical Group Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.